BRIEF published on 08/02/2024 at 22:35, 1 year 10 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 10 months ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024 Nombre total des droits de vote et d’actions au 31 juillet 2024 pour NYSE Euronext Paris (Code ISIN: FR 0010417345) : 96 498 927 actions, 96 214 457 droits de vote Autorité Des Marchés Financiers Droits De Vote Capital Social Actions NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 10 months ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
BRIEF published on 07/30/2024 at 23:35, 1 year 10 months ago DBV Technologies met à disposition son Rapport Financier Semestriel 2024 AMF Rapport Financier DBV Technologies Allergies Alimentaires Viaskin™
BRIEF published on 07/30/2024 at 23:35, 1 year 10 months ago DBV Technologies makes its 2024 Half-Year Financial Report available AMF Financial Report DBV Technologies Food Allergy Viaskin™
PRESS RELEASE published on 07/30/2024 at 23:30, 1 year 10 months ago DBV Technologies publie son Rapport Financier Semestriel 2024 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2024 et annonce sa disponibilité pour consultation en ligne ou par demande Biopharmaceutique Rapport Financier DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE published on 07/30/2024 at 23:30, 1 year 10 months ago DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2024 Half-Year Report with AMF and offers access via website or request. Company develops treatments for food allergies using Viaskin platform AMF DBV Technologies Food Allergies 2024 Half-Year Report Viaskin Platform
BRIEF published on 07/30/2024 at 22:35, 1 year 10 months ago DBV Technologies : Avancées pour Viaskin Peanut et résultats financiers au premier semestre 2024 Résultats Financiers Recherche Et Développement DBV Technologies Allergies Alimentaires Viaskin Peanut
BRIEF published on 07/30/2024 at 22:35, 1 year 10 months ago DBV Technologies: Progress for Viaskin Peanut and financial results for the first half of 2024 Financial Results Research And Development DBV Technologies Food Allergy Viaskin Peanut
Published on 06/23/2026 at 09:05, 14 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 06:45, 2 hours 34 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:45, 2 hours 34 minutes ago La confiance des CTO dans le déploiement à grande échelle de l'IA recule pour la troisième année consécutive
Published on 06/23/2026 at 06:01, 3 hours 18 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 7 hours 24 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/23/2026 at 09:00, 19 minutes ago Hong Kong unlocks new opportunities with Central Asia
Published on 06/23/2026 at 08:55, 24 minutes ago JMGO Unveils Prime Day Savings of Up to 50% Across Its Triple-Laser Projector Lineup from June 23 to July 3
Published on 06/22/2026 at 18:00, 15 hours 19 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
